HIV Testing and Diagnosis

  • Author: Peter Leone, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 1/9/18 (What's New)

Summary

  • In high-risk settings or in areas with high-risk populations, HIV testing should be coupled with screening for AHI via the HIV-1 antibody, HIV-2 antibody, and HIV-1 p24 antigen combination immunoassay[CDC HIV Testing; DHHS ART]
    • Reactive specimens should undergo HIV-1/HIV-2 antibody differentiation testing
    • Specimens initially reactive but nonreactive or indeterminate by differentiation testing should be tested for HIV-1 RNA

Action required

Keywords: Acute HIV Infection, Screening and Diagnosis, Tests and Assays

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.